Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 7/20 | 0.58 |
| ▸ | CTRB1 | P17538 | 5/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6638795 | 0.89 | ELANE (0.61) | ELANECTRB1LCKP2RX7 | |
| SCHEMBL6636149 | 0.88 | CTRB1 (0.53) | ELANECTRB1LCKP2RX7 | |
| SCHEMBL7449580 | 0.86 | CTRB1 (0.55) | ELANECTRB1LCK | |
| SCHEMBL6640343 | 0.86 | CTRB1 (0.55) | ELANECTRB1 | |
| SCHEMBL6634354 | 0.85 | CTRB1 (0.53) | ELANECTRB1P2RX7 | |
| SCHEMBL7441628 | 0.85 | ELANE (0.65) | ELANECTRB1LCK | |
| SCHEMBL6499069 | 0.85 | ELANE (0.68) | ELANECTRB1LCKP2RX7CA12 | |
| SCHEMBL6641652 | 0.84 | CTRB1 (0.57) | ELANECTRB1LCKIRAK4P2RX7 | |
| SCHEMBL6638831 | 0.83 | CTRB1 (0.54) | ELANECTRB1P2RX7 | |
| SCHEMBL6866271 | 0.81 | ELANE (0.66) | ELANECTRB1LCKP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996037485-A1 | 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | G.D. SEARLE & CO. (US) | 1996-11-28 | — | — | WO | disclosed |